BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 17307970)

  • 1. Overview of PDEs and their regulation.
    Omori K; Kotera J
    Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C; Komas N
    Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.
    Kelly MP; Brandon NJ
    Prog Brain Res; 2009; 179():67-73. PubMed ID: 20302819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
    Xu Y; Zhang HT; O'Donnell JM
    Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
    Baxendale RW; Fraser LR
    Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclic nucleotide phosphodiesterase IV expression, activity and targeting in cells of cardiovascular system].
    Yan J; Zhu HB
    Yao Xue Xue Bao; 2007 Jun; 42(6):571-5. PubMed ID: 17702390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes.
    Maurice DH
    Proc West Pharmacol Soc; 2003; 46():32-6. PubMed ID: 14699879
    [No Abstract]   [Full Text] [Related]  

  • 13. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide specific phosphodiesterases of Leishmania major.
    Johner A; Kunz S; Linder M; Shakur Y; Seebeck T
    BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
    Polson JB; Strada SJ
    Annu Rev Pharmacol Toxicol; 1996; 36():403-27. PubMed ID: 8725396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
    Lugnier C
    Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Francis SH; Blount MA; Corbin JD
    Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling human phosphodiesterase genes and splice isoforms.
    Bingham J; Sudarsanam S; Srinivasan S
    Biochem Biophys Res Commun; 2006 Nov; 350(1):25-32. PubMed ID: 16987497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.